Allen P C, Turmer A D
J Int Med Res. 1979;7(5):459-62. doi: 10.1177/030006057900700522.
Debrisan (Dextranomer) was subjected to a simple open assessment in the treatment of fifty-three chronic leg ulcers and thirty pressure sores in eight hospitals. It was found that 70% of leg ulcers and 76% of pressure sores improved, with a noticeable cleansing effect being evident in 79% and 83% respectively. No side-effects were recorded.
在八家医院，对五十三例慢性腿部溃疡和三十例压疮患者使用Debrisan（葡聚糖omer）进行了一项简单的开放式评估。结果发现，70%的腿部溃疡和76%的压疮病情有所改善，分别有79%和83%的患者出现明显的清洁效果。未记录到副作用。
